Global Cancer Treatment Drugs Sales Market Report Forecast 2017 to 2022

December 2017 | 135 pages | ID: G9BE1DF0658EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
Bristol-Myers Squibb
Takeda
Eli Lilly
Pfizer

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 CANCER TREATMENT DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Classification of Cancer Treatment Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Treatment Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Treatment Drugs Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Cancer Treatment Drugs (2012-2022)
  1.5.1 Global Cancer Treatment Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON CANCER TREATMENT DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 CANCER TREATMENT DRUGS MANUFACTURING COST ANALYSIS

3.1 Cancer Treatment Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Treatment Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Treatment Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL CANCER TREATMENT DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Cancer Treatment Drugs Market Competition by Manufacturers
  5.1.1 Global Cancer Treatment Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Cancer Treatment Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Cancer Treatment Drugs (Volume and Value) by Type
  5.5.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Treatment Drugs (Volume and Value) by Regions
  5.3.1 Global Cancer Treatment Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Cancer Treatment Drugs (Volume) by Application

6 UNITED STATES CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Cancer Treatment Drugs Sales and Value (2012-2017)
  6.1.1 United States Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Cancer Treatment Drugs Sales Price Trend (2012-2017)
6.2 United States Cancer Treatment Drugs Sales and Market Share by Manufacturers
6.3 United States Cancer Treatment Drugs Sales and Market Share by Type
6.4 United States Cancer Treatment Drugs Sales and Market Share by Application

7 CHINA CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Cancer Treatment Drugs Sales and Value (2012-2017)
  7.1.1 China Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Cancer Treatment Drugs Sales Price Trend (2012-2017)
7.2 China Cancer Treatment Drugs Sales and Market Share by Manufacturers
7.3 China Cancer Treatment Drugs Sales and Market Share by Type
7.4 China Cancer Treatment Drugs Sales and Market Share by Application

8 EUROPE CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Cancer Treatment Drugs Sales and Value (2012-2017)
  8.1.1 Europe Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Cancer Treatment Drugs Sales Price Trend (2012-2017)
8.2 Europe Cancer Treatment Drugs Sales and Market Share by Manufacturers
8.3 Europe Cancer Treatment Drugs Sales and Market Share by Type
8.4 Europe Cancer Treatment Drugs Sales and Market Share by Application

9 JAPAN CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Cancer Treatment Drugs Sales and Value (2012-2017)
  9.1.1 Japan Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Cancer Treatment Drugs Sales Price Trend (2012-2017)
9.2 Japan Cancer Treatment Drugs Sales and Market Share by Manufacturers
9.3 Japan Cancer Treatment Drugs Sales and Market Share by Type
9.4 Japan Cancer Treatment Drugs Sales and Market Share by Application

10 GLOBAL CANCER TREATMENT DRUGS MANUFACTURERS ANALYSIS

10.1 Roche
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Celgene
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Johnson & Johnson
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Bristol-Myers Squibb
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Takeda
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Eli Lilly
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Pfizer
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL CANCER TREATMENT DRUGS MARKET FORECAST (2017-2022)

13.1 Global Cancer Treatment Drugs Sales, Revenue Forecast (2017-2022)
13.2 Global Cancer Treatment Drugs Sales Forecast by Regions (2017-2022)
13.3 Global Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
13.4 Global Cancer Treatment Drugs Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure Global Sales Market Share of Cancer Treatment Drugs by Type in 2016
Table Applications of Cancer Treatment Drugs
Figure Global Sales Market Share of Cancer Treatment Drugs by Application in 2016
Figure United States Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)
Figure China Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)
Figure Global Cancer Treatment Drugs Sales and Growth Rate (2012-2022)
Figure Global Cancer Treatment Drugs Revenue and Growth Rate (2012-2022)
Table Global Cancer Treatment Drugs Sales of Key Manufacturers (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Cancer Treatment Drugs Sales Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Sales Share by Manufacturers
Table Global Cancer Treatment Drugs Revenue by Manufacturers (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Cancer Treatment Drugs Revenue Share by Manufacturers
Table 2016 Global Cancer Treatment Drugs Revenue Share by Manufacturers
Table Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Treatment Drugs by Type (2012-2017)
Figure Global Cancer Treatment Drugs Sales Growth Rate by Type (2012-2017)
Table Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Treatment Drugs by Type (2012-2017)
Figure Global Cancer Treatment Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Cancer Treatment Drugs Sales and Market Share by Regions (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Cancer Treatment Drugs by Regions (2012-2017)
Figure Global Cancer Treatment Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Cancer Treatment Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Cancer Treatment Drugs by Regions (2012-2017)
Figure Global Cancer Treatment Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Cancer Treatment Drugs Sales and Market Share by Application (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Treatment Drugs by Application (2012-2017)
Figure Global Cancer Treatment Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
Figure United States Cancer Treatment Drugs Sales Price Trend (2012-2017)
Table United States Cancer Treatment Drugs Sales by Manufacturers (2012-2017)
Table United States Cancer Treatment Drugs Market Share by Manufacturers (2012-2017)
Table United States Cancer Treatment Drugs Sales by Type (2012-2017)
Table United States Cancer Treatment Drugs Market Share by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales by Application (2012-2017)
Table United States Cancer Treatment Drugs Market Share by Application (2012-2017)
Figure China Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
Figure China Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
Figure China Cancer Treatment Drugs Sales Price Trend (2012-2017)
Table China Cancer Treatment Drugs Sales by Manufacturers (2012-2017)
Table China Cancer Treatment Drugs Market Share by Manufacturers (2012-2017)
Table China Cancer Treatment Drugs Sales by Type (2012-2017)
Table China Cancer Treatment Drugs Market Share by Type (2012-2017)
Table China Cancer Treatment Drugs Sales by Application (2012-2017)
Table China Cancer Treatment Drugs Market Share by Application (2012-2017)
Figure Europe Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Cancer Treatment Drugs Sales Price Trend (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Manufacturers (2012-2017)
Table Europe Cancer Treatment Drugs Market Share by Manufacturers (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Type (2012-2017)
Table Europe Cancer Treatment Drugs Market Share by Type (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Application (2012-2017)
Table Europe Cancer Treatment Drugs Market Share by Application (2012-2017)
Figure Japan Cancer Treatment Drugs Sales and Growth Rate (2012-2017)
Figure Japan Cancer Treatment Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Cancer Treatment Drugs Sales Price Trend (2012-2017)
Table Japan Cancer Treatment Drugs Sales by Manufacturers (2012-2017)
Table Japan Cancer Treatment Drugs Market Share by Manufacturers (2012-2017)
Table Japan Cancer Treatment Drugs Sales by Type (2012-2017)
Table Japan Cancer Treatment Drugs Market Share by Type (2012-2017)
Table Japan Cancer Treatment Drugs Sales by Application (2012-2017)
Table Japan Cancer Treatment Drugs Market Share by Application (2012-2017)
Table Roche Basic Information List
Table Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Cancer Treatment Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Treatment Drugs Global Market Share (2012-2017)
Table Celgene Basic Information List
Table Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Cancer Treatment Drugs Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Treatment Drugs Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Cancer Treatment Drugs Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Cancer Treatment Drugs Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Treatment Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Cancer Treatment Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure Global Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Cancer Treatment Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Cancer Treatment Drugs Sales Forecast by Regions (2017-2022)
Table Global Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
Table Global Cancer Treatment Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Roche Novartis Celgene Amgen Johnson & Johnson Bristol-Myers Squibb Takeda Eli Lilly Pfizer AstraZeneca Astellas Sanofi Bayer Merck & Co. Biogen Idec Kyowa Hakko Kirin Otsuka Teva Eisai Merck KGaA Ipsen AbbVie Gilead Sciences